Published in Drug Week, October 18th, 2002
"GSQ1530 is a compound derived from a newly identified class of antibiotics referred to as heteroaromatic polycyclic (HARP) antibiotics," explained Yigong Ge and colleagues working at Genesoft, Inc. in South San Francisco and Herndon, Virginia-based Focus Technologies.
GSQ1530 was highly effective against a wide range of Gram-positive microbes in vitro, including methicillin-resistant Staphylococcus aureus (MRSA), Ge and coauthors reported.
The researchers evaluated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2002-10-18)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.